Latest Us Market News

New Frontier Minerals has executed a binding option to acquire a 90% interest in the Pomme Rare Earth Element and Niobium project in Quebec, partnering with Metallium to leverage advanced processing technology and expand its critical minerals footprint.

Pro Medicus Limited has reported a stellar half-year performance with revenue up 28.4% and a surge in net profit, driven by major US contract wins and strategic investments.

The US Department of Commerce has finalized hefty antidumping and countervailing duties on Chinese graphite active anode materials, a move expected to strengthen Syrah Resources’ competitive edge in North America and accelerate its US operations.

Oneview Healthcare reported a robust 21% increase in revenue for FY2025, driven by recurring revenue growth and new customer acquisitions. The company is advancing AI-powered solutions and targeting operational breakeven in 2026.

HighCom Limited has announced a $7 million capital raise alongside a $1 million Share Purchase Plan to support working capital and product innovation, aiming for a strong revenue rebound and profitability in the second half of FY26.

Dalaroo Metals strengthens its Greenland rare earths ambitions with the appointment of industry veteran Greg Barnes and plans a US OTCQB listing to access North American capital and partnerships.

Kelly Partners Group Holdings Limited has reported a robust 17% increase in revenue for the first half of 2026, driven by strategic acquisitions and expanding international operations, particularly in the US.

Treasury Wine Estates has resolved its dispute with US distributor RNDC following RNDC’s exit from California, with a settlement impacting cash flow but supporting a positive earnings outlook for the first half of 2026.

Sims Limited is consolidating its Houston footprint by acquiring Tri Coastal Trading assets and selling its Mayo Shell property, aiming to boost EBITDA and cut costs significantly.

Imricor Medical Systems has taken a significant step toward US market entry by submitting its Advantage-MR EP Recorder/Stimulator system for FDA 510(k) clearance, aiming to enhance MRI-guided cardiac procedures.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

Nova Minerals plans to redomicile to the United States following the loss of its foreign private issuer status, while acquiring full ownership of its Estelle Gold and Critical Minerals Project and appointing a US-based CFO.